Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response
Bouchra El Hafny‐Rahbi(Centre National de la Recherche Scientifique), Claudine Kiéda(National Academy of Medicine)
Cited by 28
Related Papers
Microenvironment commits breast tumor ECs to dedifferentiation by micro-RNA-200-b-3p regulation and extracellular matrix remodeling
|Frontiers in Cell and Developmental Biology|2023|13
Tumour suppressor <scp>PTEN</scp> activity is differentially inducible by myo‐inositol phosphates
|Journal of Cellular and Molecular Medicine|2023|9
Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat
|British Journal of Pharmacology|2024|2